Skip to main content
OpenTrials
Recruiting

NCT Number: NCT05232383

Benefits and Risks of Artificial Light Exposure: Characterisation of Effects on Alertness, Sleep, Cognitive Performance, Mood and Biological Rhythms

The purpose of this project is to study the influence of light on sleep, wakefulness, EEG activity and cognitive performances.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–40 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Hôpitaux Universitaires de Strasbourg

Strasbourg, 67091, France

Location status: Recruiting

Location contact

Patrice BOURGIN, MD

CONTACT

[email protected]

03 88 11 64 30

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Male or female
  • Aged 18 to 40 years
  • With a hint of Bodymass index (BMI) between 17 and 30 kg.m - 2
  • healthy subject determined by a clinical examination, a psychological interview, a blood test, a urine analysis
  • Subject with a score<6 questionnaire PSQI ("Sleep Questionnaire Pittsburgh")
  • Subject agreeing to maintain a regular sleep/wake rhythm during the study
  • Subject agreeing to refrain from caffeine, nicotine, alcohol, psychotropic drugs, cannabis or other drugs, during the study
  • Signed informed consent
  • Subjectaffiliated to a social protection scheme

Exclusion criteria

  • somatic diseases: cardiovascular, respiratory, gastrointestinal, hematopoietic, Visual
  • immune system diseases
  • kidneys and urinary tract diseases
  • endocrine and metabolic diseases
  • neurological diseases
  • infectious diseases
  • thrombocytopenia or other malfunction of blood platelets
  • Subject with risk of thrombosis, including subject with a history of phlebitis, smoker under oral contraceptive...
  • Subject with an addiction to caffeine, nicotine, alcohol, psychotropic drugs, cannabis, or any other drug
  • Subject treatment contraindicated or inadvisable in combination with heparin
  • blood donation in the previous 3 months before the inclusion
  • Participation in other clinical trials
  • Work by shifts in the year preceding the inclusion
  • Trans-meridian travel (> 2 time zones) in the month previous the inclusion
  • Impossibility to give enlightened information (subject in an emergency situation, understanding difficulties,...)
  • Subject under safeguard of justice
  • Subject under tutorship or curatorship
  • Pregnancy (women of childbearing age)
  • Breastfeeding
  • Diet incompatible with the study's snack choices

Treatment and study plan

polychromatic light

Device

Application of polychromatic light at different times of day

red light

Device

Application of red light at different times of day

green light

Device

Application of green light at different times of day

Primary outcomes

  1. Cognitive performances assessed using N-back tasks

    Time frame: up to 56 hours

    N-Back-Task 1, 2, 3

  2. Cognitive performances assessed using Psychomotor Vigilance task (PVT)

    Time frame: up to 56 hours

    Psychomotor Vigilance task (PVT)

  3. Cognitive performances assessed using Paced Visual Serial Addition Task (PVSAT)

    Time frame: up to 56 hours

    Paced Visual Serial Addition Task (PVSAT)

Study contacts

Contact information is provided by the study sponsor or research team.

Patrice BOURGIN, MD

CONTACT

[email protected]

03 88 11 64 30 ext. 0033

Sponsors and collaborators

Lead sponsor

University Hospital, Strasbourg, France

Other

Registry information

Acronym: LumEnColor

Important dates

Study start
2021
Primary completion
2026
Study completion
2026
First posted
Feb 9, 2022
Registry last updated
Aug 8, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.